August 21st 2024, 8:10pm
By Jorge E. Cortes, MD
Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.
August 21st 2024, 8:03pm
Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.
August 21st 2024, 7:00pm
By Ashley Chan
In August 2024, the FDA approved six new cancer treatments, including some that haven’t previously been approved.
August 21st 2024, 5:00pm
By Laura Yeager
In preparation for a family member’s wedding, I purchased a new bra and protheses and felt like a princess by doing so.
August 21st 2024, 3:00pm
By Brielle Benyon
Patients with cancer who did 20-minute guided mindful breathing tended to have a more significant decrease in cancer-related pain and anxiety.
August 21st 2024, 1:00pm
By Angela Pinkins
I wrote this letter to cancer because my brother died too early.
August 20th 2024, 8:00pm
The FDA will speed up their review of Enhertu for HR-positive, HER2-low/ultralow advanced breast cancer that cannot be removed via surgery.
August 20th 2024, 5:00pm
By Jane Biehl Ph.D.
Cancer has changed my self-image, but I’ve learned a few tricks to help boost my self-confidence.
August 20th 2024, 3:00pm
By Marion Taicsich
Even when I didn’t feel like riding, brushing and grooming her kept my spirits up and provided a social outlet that wasn’t medically oriented.
August 20th 2024, 12:43pm
The Food and Drug Administration approved frontline Lazcluze plus Rybrevant for locally advanced or metastatic non-small cell lung cancer with an EGFR exon 19 deletions or exon 21 L858R substitution mutations.
August 19th 2024, 8:00pm
By Elisabeth Cancellieri, BSN, RN, OCN
I could tell from the way the staff and patients spoke of her that she was special, and I quickly saw for myself, too.
August 19th 2024, 5:00pm
By Joe Bullock
After being cancer-free for five years, I struggle with my own existence. However, I find meaning in helping others through their cancer experience.
August 19th 2024, 3:00pm
The first FDA-approved systemic therapy may be beneficial to patients with low-grade astrocytoma or oligodendroglioma with IDH1 or 2 mutations.
August 19th 2024, 1:00pm
By Chester Freeman
As I visit the cancer center for chemotherapy to treat my CLL, I can’t help but take note of how different cancer may look in each person.
August 18th 2024, 5:00pm
Cancer-related fatigue guidelines from 2024 explained which interventions help manage the side effect and explain why certain medications may not be helpful.
Rybrevant Plus Lazcluze Associated with Survival Improvement in NSCLC
Suleika Jaouad on Why Self-Advocacy Matters for Patients With Cancer
The Seasons of Cancer
What Patients With Lung Cancer Need to Know About KRAS G12C Mutations